Cutting-edge technologies in colon-targeted drug delivery systems

Expert Opinion on Drug Delivery

Volumn 8, Issue 10, 2011, Pages 1247-1258

  Patel, Mayur M ^a  

^a NIRMA UNIVERSITY   (India)

Author keywords

Colon cancer; Colon targeting; Inflammatory bowel disease; Irritable bowel syndrome; Local delivery; Microflora; Systemic therapy and technologies

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; ALPRENOLOL; ANXIOLYTIC AGENT; ATENOLOL; BUNOLOL; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DESIPRAMINE; DICLOFENAC; DICYCLOVERINE; IBUPROFEN; IMMUNOSUPPRESSIVE AGENT; LAXATIVE; MESALAZINE; METOPROLOL; NICOTINE; PARACETAMOL; PENBUTOLOL; PEPTIDE; PHENYLPROPANOLAMINE; PINAVERIUM BROMIDE; PRONETALOL; PROPANTHELINE BROMIDE; PROTEIN; PSEUDOEPHEDRINE; THEOPHYLLINE; TIMOLOL MALEATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

COLON CANCER; COLON TARGETED DRUG DELIVERY SYSTEM; CONTROLLED DRUG RELEASE; CROHN DISEASE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG TARGETING; ENTERITIS; HUMAN; INTESTINE FLORA; IRRITABLE COLON; MEDICAL TECHNOLOGY; NONHUMAN; PH; REVIEW; SYSTEMIC THERAPY; ULCERATIVE COLITIS;

ADMINISTRATION, ORAL; COLONIC DISEASES; DRUG DELIVERY SYSTEMS; EXPERT TESTIMONY; GASTROINTESTINAL AGENTS; HUMANS;

EID: 80053055956     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2011.597739     Document Type: Review

References (28)

1. Patel M, Shah T, Amin A. Therapeutic opportunities in colon specific drug delivery systems. Crit Rev Ther Drug Carrier Syst 2007;24:147-202 (Pubitemid 47324847)
2. Patel MM, Amin AA. Design and optimization of colon targeted system of theophylline for chronotherapy of nocturnal asthma. J Pharm Sci 2011;100:1760-72
3. Ashford M, Fell JT, Attwood D, et al. An in vivo investigation into the suitability of pH dependent polymers for colonic targeting. Int J Pharm 1993;95:193-9 (Pubitemid 23203152)
4. McConnell EL, Short MD, Basit AW. An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man. J Control Release 2008;130:154-60
5. Matsuda KI, Takaya T, Shimoji F, et al. Effect of food intake on the deliver of fluorescein as a model drug in colon delivery capsule after oral to beagle dogs. J Drug Target 1996;4:59-67 (Pubitemid 26381467)
6. Patel MM, Shah TJ, Amin AF, et al. Design, development and optimization of a novel time and pH-dependent colon targeted drug delivery system. Pharm Dev Technol 2009;14:62-9
7. Patel MM, Patel SL, Bhadani MN, et al. A synchronous colon specific drug delivery system for orally administered mesalamine. Acta Pharm Sci 2009;51:251-60
8. Patel MM, Amin AA. Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer. Drug Deliv 2011;18:281-93
9. Ji C, Xu H, Wu W. In vitro evaluation and pharmacokinetics in dogs of guar gum and Eudragit® FS30D-coated colon-targeted pellets of indomethacin. J Drug Target 2007;15:123-31 (Pubitemid 46957698)
10. Patel MM, Amin AF. Process, optimization and characterization of mebeverine hydrochloride loaded guar gum microspheres for irritable bowel syndrome. Carbohydr Polym 2011;published online 7 May 2011; doi:10.1016/j. carbpol.2011.04.068.
11. Moreto M, Gonalons E, Mylonakis N, et al. 3, 3-Bis-(4-hydroxyphenyl)-7- methyl-2-indolinone (BHMI), the active metabolite of the laxative sulisatin. Arzneimittel Forsch Drug Res 1979;29:1561-4 (Pubitemid 10231708)
12. Csaky TZ. Pharmacology of intestinal permeation II. Springer-Verlag; Heidelberg: 1984
13. Wroblewski S, Rihova B, Rossmann P, et al. The influence of a colonic microbiota on HPMA copolymer lectin conjugates binding in rodent intestine. J Drug Target 2001;9:85-94 (Pubitemid 32725447)
14. Galanina O, Hallouin F, Goupille C, et al. Detection of a potential receptor for the H-blood-group antigen on rat colon carcinoma cells and normal tissues. Int J Cancer 1998;76:136-40 (Pubitemid 28164580)
15. Theresa MA. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2002;2:750-63
16. Vila JI, Calpena AC, Obach R, et al. Gastric intestinal and colonic absorption of a series of beta-blockers in the rat. Int J Clin Pharmacol Ther Toxicol 1992;30:280-6
17. Godbillon J, Evard D, Vidon N, et al. Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon. Br J Clin Pharmacol 1985;19:113S-8S (Pubitemid 16193630)
18. Ishibashi T, Ikegami K, Kubo H, et al. Evaluation of colonic absorbability of drugs in dogs using a novel colon targeted delivery capsules. J Control Release 1999;59:361-76 (Pubitemid 29238178)
19. Lamprecht A, Scaffer U, Lehr CM. Size dependent bioadhesion of micro-and nanoparticulate carriers to the inflamed colonic mucosa. Pharm Res 2001;18:788-93 (Pubitemid 32783514)
20. Lamprecht A, Ubrich N, Yamamoto H, et al. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J Pharmacol Exp Ther 2001;299:775-81
21. Wilson DS, Dalmasso G, Wang L, et al. Orally delivered thioketal nanoparticles loaded with TNF-alpha-siRNA target inflammation and inhibit gene expression in the intestines. Nat Mater 2010;9:923-8
22. Rubinstein A. Colonic drug delivery. Drug Discov Today Technol 2005;2:33-7 (Pubitemid 40946306)
23. Rashid A. Dispensing device. EP0384642; 1990
24. Krogel I, Bodmeier R. Pulsatile drug release from an insoluble capsule body controlled by an insoluble plug. Pharm Res 1998;15:474-81 (Pubitemid 28175131)
25. Stevens HNE, Ross AC, Johnson JR. The hydrophilic sandwich (HS) capsule: a convenient time-delayed oral probe device. J Pharm Pharmcol 2000;52:S41
26. Ueda S, Hata T, Asakura S, et al. Development of a novel drug delivery system. Time-controlled Explosion System (TES). I. Concept and design. J Drug Target 1994;2:35-44 (Pubitemid 24106958)
27. Pozzi F, Furlani P, Gazzaniga A, et al. The Time Clock system: a new oral dosage form for fast and complete release of drug after a predetermined lag time. J Control Release 1994;31:99-108 (Pubitemid 24248121)
28. Gazzaniga A, Sangalli ME, Giordano F. Oral Chronotopic drug delivery systems: achievement of time and/or site specificity. Eur J Pharm Biopharm 1994;40:246-50 (Pubitemid 24276317)